IP Library Granted Patent US 9,568,839
Granted Patent B2
US 9,568,839 · App. 12/400,493 · Granted Feb 14, 2017

Method for producing polymers

Inventors: Peer F. Stähler (Mannheim, DE); Cord F. Stähler (Hirshberg a.d. Bergstrasse/Grossachsen, DE); Manfred Müller (Ladenburg, DE)
Assignee: Synthetic Genomics, Inc.
G03F7/70216B01J19/0046B01J19/0093B01L3/5085B01L3/502707B82Y30/00C12N15/10C12N15/66C12P19/34B01J2219/0059B01J2219/00317B01J2219/00432B01J2219/00436B01J2219/00439B01J2219/00441B01J2219/00448B01J2219/00479B01J2219/00497B01J2219/00511B01J2219/00529B01J2219/00585B01J2219/00596B01J2219/00603B01J2219/00605B01J2219/00608B01J2219/00621B01J2219/00626B01J2219/00648B01J2219/00659B01J2219/00675B01J2219/00689B01J2219/00702B01J2219/00704B01J2219/00711B01J2219/00722B01J2219/00725B01L2300/069B01L2300/0654B01L2300/0864C40B40/06C40B40/10C40B50/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,568,839
App. No.
12/400,493
Granted
Feb 14, 2017
Kind
B2
Abstract

The invention relates to a method for producing polymers, in particular synthetic nucleic acid double strands of optional sequence, comprising the steps: (a) provision of a support having a surface area which contains a plurality of individual reaction areas, (b) location-resolved synthesis of nucleic acid fragments having in each case different base sequences in several of the individual reaction areas, and (c) detachment of the nucleic acid fragments from individual reaction areas.

Claims (14)

1. A method for optimizing the functional genetic parameters of genetic elements, comprising:

(a) providing a digital sequence of a variant of a known genetic element,

(b) fragmenting the digital sequence of step (a) into a plurality of suitable complementary oligomeric building blocks that can assemble to form a nucleic acid double-stranded hybrid,

(c) synthesizing the plurality of oligomeric building blocks by parallel synthesis steps, wherein each oligomeric building block is synthesized on a different area of a common support,

(d) detaching the oligomeric building blocks from the support,

(e) bringing the oligomeric building blocks into contact with one another,

(f) linking the oligomeric building blocks enzymatically to form the variant of the known genetic element,

(g) introducing the variant directly into a target cell and observing a result, and

(h) comparing the result obtained in step (g) with a reference result of the known genetic element.

2. The method according to claim 1 , wherein the genetic elements are selected from the group consisting of genes, parts of genes, regulatory elements or viral packaging signals.

3. The method according to claim 1 , wherein the digital sequences are derived from a database.

4. Method according to claim 1 , wherein the variants are generated by random composition.

5. The method according to claim 1 , wherein the variants are generated for optimizing codon usage.

6. The method according to claim 1 , wherein in step (b) biochemical and functional parameters are taken into account for generating the variants.

Assignments (8)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (TERM) Recorded Jul 16, 2024
From: MIDCAP FINANCIAL TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0070 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (REVOLVING) Recorded Jul 16, 2024
From: MIDCAP FUNDING IV TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0001 →
SECURITY AGREEMENT SUPPLEMENT (TERM) Recorded Jan 26, 2024
From: TELESIS BIO INC.; ETONBIO, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 066372/0745 →
SECURITY AGREEMENT SUPPLEMENT (REVOLVING) Recorded Jan 26, 2024
From: TELESIS BIO INC.; ETONBIO, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 066372/0761 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2020
From: OXFORD FINANCE LLC
To: SYNTHETIC GENOMICS, INC.; GENOVIA BIO, LLC; GREEN RESOURCES, LLC; SGI-DNA, INC.; SYNTHETIC GENOMICS VACCINES, INC.
Reel/Frame 054372/0822 →
CHANGE OF NAME Recorded May 19, 2020
From: SGI-DNA, INC.
To: CODEX DNA, INC.
Reel/Frame 052705/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2019
From: SYNTHETIC GENOMICS, INC.
To: SGI-DNA, INC.
Reel/Frame 049602/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2012
From: FEBIT HOLDING GMBH
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 028814/0354 →
Priority Claims (5)
DE 199 07 080 · Feb 19, 1999 · national
DE 199 28 843 · Jun 24, 1999 · national
DE 199 40 752 · Aug 27, 1999 · national
WO PCT/EP99/06316 · Aug 27, 1999 · international
DE 199 57 116 · Nov 26, 1999 · national
Continuity (4)
Continuation 11785505 · Apr 18, 2007
Division 10455369 · Jun 6, 2003
Division 09869332
Related Publication 20090170802A1 · Jul 2, 2009